Browse Result
Total number of records for Asthma in Broncho Alveolar Lavage Fluid (BALF) of Human in DAAB (Version-2) database: 295
| Record no | Disease | Organism | Sample | Gene Name | Techniques | Omics | Study | Comments | Pubmed ID |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | ACE | LC-MS/MS | Proteomics | High Throughput | It is a serum protein and upregulated after allergen challenge. | 15951573 |
| 2 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | S100A8 | LC-MS/MS | Proteomics | High Throughput | This acute phase protein is up regulated in allergic asthma. | 15951573 |
| 3 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CD14 | LC-MS/MS | Proteomics | High Throughput | This protein is upregulated after segmental allergen challenge in allergic asthma. | 15951573 |
| 4 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | S100A9 | LC-MS/MS | Proteomics | High Throughput | Expression significantly increased after allergen challenge. | 15951573 |
| 5 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | S100A12 | LC-MS/MS | Proteomics | High Throughput | This neutrophilic granule protein is upregulated in allergic asthma. | 15951573 |
| 6 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | MST1 | LC-MS/MS | Proteomics | High Throughput | Upregulated after allergen challenge. | 15951573 |
| 7 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | MPO | LC-MS/MS | Proteomics | High Throughput | Upregulated in asthmatic airways after allergen challenge | 15951573 |
| 8 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CLC | LC-MS/MS | Proteomics | High Throughput | It is an eosinophil granule specific protein produced after eosinophil activation in airways | 15951573 |
| 9 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CFH | LC-MS/MS | Proteomics | High Throughput | CFH was differentially expressed after allergen challenge. | 15951573 |
| 10 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CFB | LC-MS/MS | Proteomics | High Throughput | CFB was differentially expressed after allergen challenge. | 15951573 |
| 11 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | ITIH1 | LC-MS/MS | Proteomics | High Throughput | ITIH1 was differentially expressed after allergen challenge. | 15951573 |
| 12 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CAT | LC-MS/MS | Proteomics | High Throughput | CAT was differentially expressed after allergen challenge. | 15951573 |
| 13 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | PON1 | LC-MS/MS | Proteomics | High Throughput | PON1 was differentially expressed after allergen challenge. | 15951573 |
| 14 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | BPIFA1 | LC-MS/MS | Proteomics | High Throughput | Host defense proteins involved in innate immunity against pathogens | 15951573 |
| 15 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | SFTPB | LC-MS/MS | Proteomics | High Throughput | Synthesized by lung Epithelial Cells and participates in early defense against pathogens | 15951573 |
| 16 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | ORM1 | LC-MS/MS | Proteomics | High Throughput | An acute phase protein | 15951573 |
| 17 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | APOB | LC-MS/MS | Proteomics | High Throughput | APOB was differentially expressed after allergen challenge. | 15951573 |
| 18 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | APOA1 | LC-MS/MS | Proteomics | High Throughput | APOA1 was differentially expressed after allergen challenge. | 15951573 |
| 19 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CP | LC-MS/MS | Proteomics | High Throughput | A serum protein which is a biomarkers of allergic inflammation | 15951573 |
| 20 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | TUBA1A | LC-MS/MS | Proteomics | High Throughput | Structural protein involved in airway remodelling | 15951573 |
| 21 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IGHM | LC-MS/MS | Proteomics | High Throughput | Involved in immune response(present in supplimentary table) | 15951573 |
| 22 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | DSP | LC-MS/MS | Proteomics | High Throughput | DSP was differentially expressed after allergen challenge. | 15951573 |
| 23 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | PIR | LC-MS/MS | Proteomics | High Throughput | PIR was down regulated after allergen challenge. | 15951573 |
| 24 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) and Macrophages | TGFB1 | real-time PCR and immunoassay and fluorescent microscopy | Genomics, Others | Low Throughput | Children with severe asthma have increased airway TGFβ1 expression and activation associated with an increased airway oxidant burden. Oxidant stress may mediate the effects of TGFβ1 and promote airway remodeling in children with severe asthma. | 22206775 |
| 25 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL13 | Immunoassay | Others | Low Throughput | TGF-β1 activation was also greater in children with severe asthma and was associated with higher IL-13 concentrations. | 22206775 |
| 26 | Asthma and obesity | Human | Broncho Alveolar Lavage Fluid (BALF) and Plasma | ADIPOQ | ELISA | Others | Low Throughput | Increasing BMI was marginally and inversely associated with BAL adiponectin. | 21332421 |
| 27 | Asthma and obesity | Human | Broncho Alveolar Lavage Fluid (BALF) and Plasma | LEP | ELISA | Others | Low Throughput | Obesity was associated with higher BAL and plasma leptin levels in asthmatics and controls. | 21332421 |
| 28 | Asthma. | Human | Fibroblasts from Broncho Alveolar Lavage Fluid (BALF) | RHOA | MALDI Tof Tof | Proteomics | High Throughput | Involved in cellular migration and overexpressed in mild asthma. | 16430780 |
| 29 | Asthma. | Human | Fibroblasts from Broncho Alveolar Lavage Fluid (BALF) | RAC1 | MALDI Tof Tof | Proteomics | High Throughput | Overexpressed in mild asthma. | 16430780 |
| 30 | Asthma. | Human | Fibroblasts from Broncho Alveolar Lavage Fluid (BALF) | FN1 | MALDI Tof Tof | Proteomics | High Throughput | 5 fold increase was observed in mild asthma patients. | 16430780 |
| 31 | Asthma. | Human | Fibroblasts from Broncho Alveolar Lavage Fluid (BALF) | SRSF3 | MALDI Tof Tof | Proteomics | High Throughput | 1.4 fold increase was observed in patients suffering from mild asthma. | 16430780 |
| 32 | Asthma. | Human | Fibroblasts from Broncho Alveolar Lavage Fluid (BALF) | ACTA2 | MALDI Tof Tof | Proteomics | High Throughput | Overexpressed in mild asthma. | 16430780 |
| 33 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | MST1 | LC-MS/MS | Proteomics | High Throughput | This growth factor is up regulated in allergic asthma. | 15951573 |
| 34 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | IGFBP2 | LC-MS/MS | Proteomics | High Throughput | This growth factor is up regulated in allergic asthma. | 15951573 |
| 35 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | IGFBP3 | LC-MS/MS | Proteomics | High Throughput | This growth factor is up regulated in allergic asthma. | 15951573 |
| 36 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | OGN | LC-MS/MS | Proteomics | High Throughput | This growth factor is up regulated in allergic asthma. | 15951573 |
| 37 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CCL17 | LC-MS/MS | Proteomics | High Throughput | This chemokine is up regulated in allergic asthma. | 15951573 |
| 38 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ADIPOQ | LC-MS/MS | Proteomics | High Throughput | This growth factor is up regulated in allergic asthma. | 15951573 |
| 39 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | IGFBP6 | LC-MS/MS | Proteomics | High Throughput | This growth factor is up regulated in allergic asthma. | 15951573 |
| 40 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | MMP9 | LC-MS/MS | Proteomics | High Throughput | This neutrophilic granule protein is upregulated in allergic asthma. | 15951573 |
| 41 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | LCN2 | LC-MS/MS | Proteomics | High Throughput | This neutrophilic granule protein is upregulated in allergic asthma. | 15951573 |
| 42 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | GPLD1 | LC-MS/MS | Proteomics | High Throughput | This granule protein is upregulated in allergic asthma. | 15951573 |
| 43 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CLC | LC-MS/MS | Proteomics | High Throughput | This eosinophilic granule protein is upregulated in allergic asthma. | 15951573 |
| 44 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PRG2 | LC-MS/MS | Proteomics | High Throughput | This eosinophilic granule protein is upregulated in allergic asthma. | 15951573 |
| 45 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CRISP3 | LC-MS/MS | Proteomics | High Throughput | This neutrophilic granule protein is upregulated in allergic asthma. | 15951573 |
| 46 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | RNASE3 | LC-MS/MS | Proteomics | High Throughput | This eosinophilic granule protein is upregulated in allergic asthma. | 15951573 |
| 47 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CFH | LC-MS/MS | Proteomics | High Throughput | This complement factor is upregulated in allergic asthma. | 15951573 |
| 48 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CFB | LC-MS/MS | Proteomics | High Throughput | This complement factor is upregulated in allergic asthma. | 15951573 |
| 49 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | C6 | LC-MS/MS | Proteomics | High Throughput | This complement factor is upregulated in allergic asthma. | 15951573 |
| 50 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | C8A | LC-MS/MS | Proteomics | High Throughput | This complement factor is upregulated in allergic asthma. | 15951573 |
| 51 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | C8G | LC-MS/MS | Proteomics | High Throughput | This complement factor is upregulated in allergic asthma. | 15951573 |
| 52 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CFD | LC-MS/MS | Proteomics | High Throughput | This complement factor is upregulated in allergic asthma. | 15951573 |
| 53 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | C1QC | LC-MS/MS | Proteomics | High Throughput | This complement factor is upregulated in allergic asthma. | 15951573 |
| 54 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ITIH1 | LC-MS/MS | Proteomics | High Throughput | This protease inhibitor is upregulated in allergic asthma. | 15951573 |
| 55 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SERPINA3 | LC-MS/MS | Proteomics | High Throughput | This protease inhibitor is upregulated in allergic asthma. | 15951573 |
| 56 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SERPINA4 | LC-MS/MS | Proteomics | High Throughput | This protease inhibitor is upregulated in allergic asthma. | 15951573 |
| 57 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SERPINF1 | LC-MS/MS | Proteomics | High Throughput | This protease inhibitor is upregulated in allergic asthma. | 15951573 |
| 58 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CTSD | LC-MS/MS | Proteomics | High Throughput | This protease is upregulated in allergic asthma. | 15951573 |
| 59 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PSME1 | LC-MS/MS | Proteomics | High Throughput | This protease is upregulated in allergic asthma. | 15951573 |
| 60 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | FETUB | LC-MS/MS | Proteomics | High Throughput | This protease is upregulated in allergic asthma. | 15951573 |
| 61 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ITIH3 | LC-MS/MS | Proteomics | High Throughput | This protease inhibitor is upregulated in allergic asthma. | 15951573 |
| 62 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CPB2 | LC-MS/MS | Proteomics | High Throughput | This protease is upregulated in allergic asthma. | 15951573 |
| 63 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CAMP | LC-MS/MS | Proteomics | High Throughput | This protease is upregulated in allergic asthma. | 15951573 |
| 64 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PSME2 | LC-MS/MS | Proteomics | High Throughput | This protease is upregulated in allergic asthma. | 15951573 |
| 65 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CPN1 | LC-MS/MS | Proteomics | High Throughput | This protease is upregulated in allergic asthma. | 15951573 |
| 66 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | TIMP1 | LC-MS/MS | Proteomics | High Throughput | This protease inhibitor is upregulated in allergic asthma. | 15951573 |
| 67 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | MASP2 | LC-MS/MS | Proteomics | High Throughput | This protease is upregulated in allergic asthma. | 15951573 |
| 68 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CAT | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 69 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PKM | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 70 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | TKT | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 71 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PON1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 72 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | LDHB | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 73 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ASAH1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 74 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | GAPDH | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 75 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CD5L | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 76 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | NME2 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 77 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ADH5 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 78 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ADH1B | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 79 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | GSR | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 80 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | TXN | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 81 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | NAGK | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 82 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PDXK | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 83 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | GPX3 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 84 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PYGL | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 85 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | GPX4 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 86 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | TXNDC17 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 87 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PCBD1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 88 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PTGDS | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 89 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ANG | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 90 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CDA | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 91 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | BPIFB1 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 92 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CHI3L2 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 93 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | AZGP1 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 94 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CHI3L1 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 95 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SFTPB | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 96 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PGLYRP1 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 97 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | THBS1 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 98 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | MBL2 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 99 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | LBP | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 100 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | FCN3 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 101 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | BPIFA1 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 102 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ITLN1 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 103 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | FCN2 | LC-MS/MS | Proteomics | High Throughput | This local matrix protein is up regulated in allergic asthma. | 15951573 |
| 104 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ORM1 | LC-MS/MS | Proteomics | High Throughput | This acute phase protein is up regulated in allergic asthma. | 15951573 |
| 105 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SAA4 | LC-MS/MS | Proteomics | High Throughput | This acute phase protein is up regulated in allergic asthma. | 15951573 |
| 106 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APCS | LC-MS/MS | Proteomics | High Throughput | This acute phase protein is up regulated in allergic asthma. | 15951573 |
| 107 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | S100A4 | LC-MS/MS | Proteomics | High Throughput | This acute phase protein is up regulated in allergic asthma. | 15951573 |
| 108 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CRP | LC-MS/MS | Proteomics | High Throughput | This acute phase protein is up regulated in allergic asthma. | 15951573 |
| 109 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOB | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 110 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOA4 | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 111 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOE | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 112 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CLU | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 113 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOH | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 114 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOL1 | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 115 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOD | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 116 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOA2 | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 117 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOM | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 118 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOC1 | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 119 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOC2 | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 120 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOC3 | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 121 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | APOC4 | LC-MS/MS | Proteomics | High Throughput | This apolipoprotein is up regulated in allergic asthma. | 15951573 |
| 122 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CP | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 123 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PLG | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 124 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | GC | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 125 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | FGA | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 126 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | LTF | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 127 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | AMBP | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 128 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | HRG | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 129 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | FBLN1 | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 130 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | AHSG | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 131 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SERPINA7 | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 132 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | F9 | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 133 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | F10 | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 134 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | MB | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 135 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | THBS4 | LC-MS/MS | Proteomics | High Throughput | This serum protein is up regulated in allergic asthma. | 15951573 |
| 136 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | TUBB4B | LC-MS/MS | Proteomics | High Throughput | This cytoskeletal protein is up regulated in allergic asthma. | 15951573 |
| 137 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | LRG1 | LC-MS/MS | Proteomics | High Throughput | This cytoskeletal protein is up regulated in allergic asthma. | 15951573 |
| 138 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | COTL1 | LC-MS/MS | Proteomics | High Throughput | This cytoskeletal protein is up regulated in allergic asthma. | 15951573 |
| 139 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ZG16B | LC-MS/MS | Proteomics | High Throughput | This cytoskeletal protein is up regulated in allergic asthma. | 15951573 |
| 140 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ARPC4 | LC-MS/MS | Proteomics | High Throughput | This cytoskeletal protein is up regulated in allergic asthma. | 15951573 |
| 141 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ARPC1B | LC-MS/MS | Proteomics | High Throughput | This cytoskeletal protein is up regulated in allergic asthma. | 15951573 |
| 142 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | DSP | LC-MS/MS | Proteomics | High Throughput | This cytoskeletal protein is up regulated in allergic asthma. | 15951573 |
| 143 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ACTR3 | LC-MS/MS | Proteomics | High Throughput | This cytoskeletal protein is up regulated in allergic asthma. | 15951573 |
| 144 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ANXA3 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 145 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ARF3 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 146 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SHBG | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 147 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | RAN | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 148 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | RSU1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 149 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | HMGB1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 150 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | RPS12 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 151 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ANXA11 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 152 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | HSPE1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 153 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | GNB2L1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 154 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | DYNLRB1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 155 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CNTN1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 156 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SEPP1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 157 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | MNDA | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 158 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | HNRNPC | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 159 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SUB1 | LC-MS/MS | Proteomics | High Throughput | This protein is up regulated in allergic asthma. | 15951573 |
| 160 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SUSD2 | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 161 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | GPR116 | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 162 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SPINT1 | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 163 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CD55 | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 164 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PTPRS | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 165 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PLXND1 | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 166 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CNTN6 | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 167 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | CNTN1 | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 168 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | ACE | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 169 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | NTM | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 170 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | SLC34A2 | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 171 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | NRP1 | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 172 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | PIR | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 173 | Asthma induced by allergen challenge | Human | Broncho Alveolar Lavage Fluid (BALF) | OSCAR | LC-MS/MS | Proteomics | High Throughput | This protein is down regulated in allergic asthma. | 15951573 |
| 174 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL33 | Meso Scale Discovery system | Others | Low Throughput | IL-33 was significantly elevated in BALF from asthmatic patients compared with controls. It was significantly elevated in asthmatics treated with ICS, with or without additional oral corticosteroids, compared with those not so treated. It was slightly, but significantly elevated in asthmatics not treated with steroids compared with control subjects. BALF concentrations of IL-33 correlated inversely with lung function (FEV1%). | 29453280 |
| 175 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | TSLP | ELISA | Others | Low Throughput | TSLP was significantly elevated in BALF from asthmatic patients compared with controls. It was significantly elevated in BALF of patients treated with ICS or without oral corticosteroid compared with those not so treated. The median BALF concentration of TSLP was significantly elevated in asthmatics not treated with steroids compared with control subjects. BALF concentrations of TSLP correlated inversely with lung function (FEV1%). | 29453280 |
| 176 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL4 | Meso Scale Discovery system | Others | Low Throughput | IL-4 was significantly greater in BALF from asthmatic patients compared with. It was significantly elevated in ICS-treated asthmatics compared with asthmatics not treated with steroids. IL-4 was significantly higher in BALF from asthmatics not treated with steroids than in control subjects. | 29453280 |
| 177 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL5 | Meso Scale Discovery system | Others | Low Throughput | IL-5 was significantly greater in BALF from asthmatics compared with controls. It was significantly elevated in ICS-treated asthmatics compared with asthmatics not treated with steroids. | 29453280 |
| 178 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL13 | Meso Scale Discovery system | Others | Low Throughput | IL-13 was significantly greater in BALF from asthmatics compared to controls. It was significantly elevated in ICS-treated asthmatics compared with asthmatics not treated with steroids. IL-13 was significantly higher in asthmatics not treated with steroids than in control subjects. IL-13 concentration in BALF correlated inversely with FEV1%. | 29453280 |
| 179 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | EGF | Multiplex multianalyte technology | Others | High Throughput | A significant increase in BALF levels of EGF in patients with mild-tomoderate asthma in relation to control subjects.The level progressively gor downregulated in patients with severe asthma. | 27001157 |
| 180 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | bFGF | Multiplex multianalyte technology | Others | High Throughput | A significant increase in BALF levels of bFGF in patients with mild-tomoderate asthma in relation to control subjects.The level progressively gor downregulated in patients with severe asthma. | 27001157 |
| 181 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | PDGF-BB | Multiplex multianalyte technology | Others | High Throughput | A significant increase in BALF levels of PDGF-BB in patients with mild-tomoderate asthma in relation to control subjects.The level progressively gor downregulated in patients with severe asthma. | 27001157 |
| 182 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | Tryptase | ImmunoCAP Assay | Others | Low Throughput | A greater prevalence of patients with detectable BALF levels of tryptase was found in patients with severe compared with those with mild-to-moderate asthma. | 27001157 |
| 183 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | Trypsin | ELISA | Others | Low Throughput | BALF levels of trypsin tended to increase in severe asthma patients in ASM Quartile 3 and Quartile 4 compared with those in the other patient groups and control group. | 27001157 |
| 184 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | TF | ELISA | Others | Low Throughput | TF was significantly augmented in BAL fluid of patients with severe asthma belonging to all ASM quartiles compared with control subjects. | 27001157 |
| 185 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | KLK14 | ELISA | Others | Low Throughput | KLK14 level in BALF of severe asthmatics was higher as compared with control subjects. | 27001157 |
| 186 | Severe Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | LTB4 | Enzyme Immunoassay (EIA) | Others | Low Throughput | LTB4 concentrations were elevated in BAL fluid from patients with severe asthma, including those with isolated eosinophilic inflammation, and these eosinophils displayed LTA4H via Immunohistochemistry. | 30352167 |
| 187 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | sHLA-G | ELISA | Others | Low Throughput | Elevated levels of soluble humanleukocyte antigen-G in the airways are a marker for a low-inflammatory endotype of asthma. | 28363527 |
| 188 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | ADAM33 | Western Blotting, FRET peptide cleavage assay | Proteomics, Others | Low Throughput | ADAM33 level and activity increased in bronchoalveolar lavage fluid (BALF) of asthmatic patients as compared to healthy controls. | 27489884 |
| 189 | Severe Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CXCL10 | qRT-PCR | Genomics | Low Throughput | CXCL10 expression is elevated in severe asthma and associated with poor asthma control. High CXCL10 gene expression was associated with a mast cell signature in humans. | 28679952 |
| 190 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF), Serum | MCP1 | ELISA | Others | Low Throughput | The serum and BALF level of MCP1 were significantly elevated in asthmatics as compared to healthy controls. | 29755573 |
| 191 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF), Serum | IL6 | ELISA | Others | Low Throughput | The serum and BALF level of IL6 were elevated in asthmatics as compared to healthy controls. Serum IL6 showed a negative correlation with Der p1 specific IgE (class) in the total asthmatic group based on Pearson’s correlation coefficients. | 29755573 |
| 192 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF), Serum | IL8 | ELISA | Others | Low Throughput | The serum and BALF level of IL8 were elevated in asthmatics as compared to healthy controls. | 29755573 |
| 193 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF), Serum | RANTES | ELISA | Others | Low Throughput | The serum and BALF level of RANTES were significantly elevated in asthmatics as compared to healthy controls. | 29755573 |
| 194 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF), Serum | MIP-1alpha | ELISA | Others | Low Throughput | Serum MIP-1alpha was significantly lower in asthmatic group as compared to normal controls. BALF level of MIP-1alpha was significantly raised in asthmatic group as compared to normal control group. | 29755573 |
| 195 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF), Serum | TARC | ELISA | Others | Low Throughput | Serum TARC level was lowered while TARC level in BALF was raised in asthmatics as compared to normal controls. TARC levels in serum were strongly elevated in the elderly adult group relative to the young adults and the middle aged adult groups. TARC in serum was related to total IgE in serum in the elderly adult group. | 29755573 |
| 196 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF), Serum | IL4 | ELISA | Others | Low Throughput | The serum and BALF level of IL4 were elevated in asthmatics as compared to healthy controls. | 29755573 |
| 197 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF), Serum | IFNG | ELISA | Others | Low Throughput | Serum and BALF level of IFNG were slightly increased in asthmatics as compared to healthy controls. | 29755573 |
| 198 | Severe Asthma | Human | Lung Tissues, Bronchial Epithelial Cells, Broncho Alveolar Lavage Fluid (BALF), Airway Epithelial Cell Culture | SEMA3E | Immunohistochemistry, qRT-PCR, ELISA | Others, Genomics, Others | Low Throughput | Semaphorin 3E is diminished in the airways of severe allergic asthmatic patients. This study suggests a potential role of Semaphorin3E in the pathogenesis of asthma severity. | 28506853 |
| 199 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL7 | Luminex Assay | Others | High Throughput | IL17 level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 200 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL1RA | Luminex Assay | Others | High Throughput | IL1RA level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 201 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | EGF | Luminex Assay | Others | High Throughput | EGF level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 202 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | TGFA | Luminex Assay | Others | High Throughput | TGFα level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 203 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | CCL11 | Luminex Assay | Others | High Throughput | CCL11 level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 204 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | CCL15 | Luminex Assay | Others | High Throughput | CCL15 level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 205 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | CCL17 | Luminex Assay | Others | High Throughput | CCL17 level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 206 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | TRAIL | Luminex Assay | Others | High Throughput | TRAIL level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 207 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL1B | Luminex Assay | Others | High Throughput | IL1B level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 208 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL5 | Luminex Assay | Others | High Throughput | IL5 level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 209 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | CX3CL1 | Luminex Assay | Others | High Throughput | CX3CL1 level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 210 | Asthma (Fungi induced asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | GM-CSF | Luminex Assay | Others | High Throughput | GM-CSF level was significantly higher in BALF of fungal asthmatics as compared to non fungal asthmatics. | 29907867 |
| 211 | Asthma | Human | Serum, Broncho Alveolar Lavage Fluid (BALF) | SP-D | ELISA, Western Blotting | Others, Proteomics | Low Throughput | SP-D concentrations in BAL samples declined and serum concentrations increased in patients with treatment-resistant severe asthma. Because reduced BAL concentrations of SP-D are reflected by elevated serum SP-D concentrations, measures of serum SP-D may serve as a potential biomarker of airway events underlying treatment-resistant asthma. The structural integrity of SP-D in the BAL and serum samples of patients with severe asthma was found to be compromised. | 26836907 |
| 212 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | MPO | ELISA | Others | Low Throughput | BAL concentrations of MPO were increased in patients with severe asthma compared with patients with mild asthma and healthy control subjects. | 26836907 |
| 213 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | ECP | ELISA | Others | Low Throughput | BAL concentrations of ECP were increased in patients with severe asthma compared with patients with mild asthma and healthy control subjects. | 26836907 |
| 214 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL8 | ELISA | Others | Low Throughput | BAL concentrations of IL8 were increased in patients with severe asthma compared with patients with mild asthma and healthy control subjects. | 26836907 |
| 215 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | NE | ELISA | Others | Low Throughput | Neutrophil elastase levels were significantly increased in BAL specimens from patients with severe asthma compared with specimens from healthy control subjects and patients with mild asthma. | 26836907 |
| 216 | Asthma | Human | Alveolar Macrophages from Broncho Alveolar Lavage Fluid (BALF) | CD163 | Confocal Immunofluorescence Microscopy | Others | Low Throughput | Alveolar Macrophages derived from Asthmatic Patients Have Reduced Cell Surface Expression of CD163 as compared to that from healthy subjects. | 26376364 |
| 217 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF), Sputum | FXIII | qRT-PCR, Western Blotting | Genomics, Proteomics | Low Throughput | FXIII expression was upregulated in the airways of asthmatic patients after allergen exposure. Expression in the sputum of asthmatic patients correlated with the type 2 immune response and airflow limitation. Excessive activity of FXIII could contribute to the pathophysiology of airway obstruction in asthmatic patients. | 26525229 |
| 218 | Asthma (Alveolar Proteinosis) | Human | Broncho Alveolar Lavage Fluid (BALF) | SP-A2 | Genotyping | Genomics | Low Throughput | Genetic variation in SP-A2 at position SP-A2 Gln223Lys is an important mediator of eosinophil activities, which may lead to a more severe asthma phenotype. | 27027938 |
| 219 | Severe Asthma | Human | Serum, Broncho Alveolar Lavage Fluid (BALF), Bronchial Biopsy | INHBA | ELISA, Immunofluorescence | Others | Low Throughput | Activin-A expression was significantly elevated in serum, BALF and bronchial tissue of the asthmatics as compared to healthy subjects. Activin-A has anti-angiogenic effects in vitro that are not propagated in vivo, where reduced basal expression of its receptors is observed particularly in severe asthma. | 26869672 |
| 220 | Severe Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL8 | ELISA | Others | Low Throughput | The median concentration of IL18 was significantly lower in the BALF of severely asthmatic patients compared to healthy controls. | 26869672 |
| 221 | Severe Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | VEGF | ELISA | Others | Low Throughput | VEGF level was significantly increased in severe asthmatics as compared to healthy subjects. | 26869672 |
| 222 | Severe Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | sVEGFR1 | ELISA | Others | Low Throughput | The median concentration of sVEGFR1 was significantly lower in the BALF of severely asthmatic patients compared to healthy controls. | 26869672 |
| 223 | Asthma | Human | Sputum, Broncho Alveolar Lavage Fluid (BALF), Lung Tissues, BAL cells | FSTL1 | Proteomic Array, Immunohistochemistry, qRT-PCR | Proteomics, Others, Genomics | High Throughput, Low Throughput | FSTL1 is >200 fold more highly expressed in the asthma compared to the control subjects. Segmental allergen challenge induced increased levels of BAL FSTL1. BAL macrophages both expressed FSTL1 and could be induced by FSTL1 to express MMP9 suggesting a potential role of FSTL1 in remodeling. | 27001159 |
| 224 | Asthma | Human | Respiratory Tract Lining Fluids (RTLFs), Bronchial Wash, Broncho Alveolar Lavage Fluid (BALF) | SP-A | LC-MS/MS, ELISA | Proteomics, Others | High Throughput, Low Throughput | The asthmatic coronal proteome and respiratory tract lining fluids (RTLFs) displayed a reduced contribution SP-A as compared to that in healthy subjects. | 28647590 |
| 225 | Asthma | Human | Respiratory Tract Lining Fluids (RTLFs), Bronchial Wash, Broncho Alveolar Lavage Fluid (BALF) | α1AT | LC-MS/MS, ELISA | Proteomics, Others | High Throughput, Low Throughput | 1.7 fold increase in α1-antitrypsin was observed in asthmatics as compared to healthy controls. | 28647590 |
| 226 | Asthma | Human | Respiratory Tract Lining Fluids (RTLFs), Bronchial Wash, Broncho Alveolar Lavage Fluid (BALF) | IgA | LC-MS/MS, ELISA | Proteomics, Others | High Throughput, Low Throughput | IgA was elevated in asthmatics as compared to healthy subjects. | 28647590 |
| 227 | Asthma | Human | Respiratory Tract Lining Fluids (RTLFs), Bronchial Wash, Broncho Alveolar Lavage Fluid (BALF) | TF | LC-MS/MS, ELISA | Proteomics, Others | High Throughput, Low Throughput | Transferrin appeared to be most depressed within the mild asthmatic corona by 0.16 fold. | 28647590 |
| 228 | Asthma | Human | Respiratory Tract Lining Fluids (RTLFs), Bronchial Wash, Broncho Alveolar Lavage Fluid (BALF) | LYZ | LC-MS/MS, ELISA | Proteomics, Others | High Throughput, Low Throughput | Lysozyme appeared to be most depressed within the mild asthmatic corona by 0.34-fold. | 28647590 |
| 229 | Asthma, COPD | Human | Broncho Alveolar Lavage Fluid (BALF) | IL6 | ELISA | Others | Low Throughput | IL6 in BALF of COPD was higher than in asthmatics. IL6/IL13 ratio measured in BALF was higher in COPD patients than in asthmatics and therefore, it could effectively differentiate the two diseases. | 28791839 |
| 230 | Asthma, COPD | Human | Broncho Alveolar Lavage Fluid (BALF) | IL13 | ELISA | Others | Low Throughput | IL13 in BALF of COPD was slightly higher than in asthmatics. IL6/IL13 ratio measured in BALF was higher in COPD patients than in asthmatics and therefore, it could effectively differentiate the two diseases. | 28791839 |
| 231 | Allergic Asthma (Inhaled Allergen Challenge) | Human | Broncho Alveolar Lavage Fluid (BALF), Bronchial Brushings, Plasma, Urine | CC16 | ELISA, Immunocytochemistry, qRT-PCR | Others, Genomics | Low Throughput | An inhaled allergen challenge in asthmatic subjects leads to an increase in plasma CC16, with increasing CC16 levels in BAL fluid of some subjects but without any signs of altered CC16 mRNA expression in brush samples or urinary CC16. Levels of CC16 in plasma and in the alveolar fraction of BAL correlated significantly after the challenge. CC16 serves as a a biomarker of epithelial dysfunction. | 28862880 |
| 232 | Asthma (Steroid Naïve Asthma) | Human | Bronchial Epithelial Cells (BECs), Lung Biopsy, Broncho Alveolar Lavage Fluid (BALF), Serum | ITLN1 | qRT-PCR, Immunohistochemistry, ELISA | Genomics, Others | Low Throughput | ITLN1 mRNA expression in freshly isolated BECs was significantly higher in the Steroid Naive (SN) Asthma group than in Steroid treated asthmatics and healthy controls in both distal and proximal airway samples. ITLN1 mRNA was also positively correlated with iNOS, CCL26, periostin and DPP4 mRNA. ITLN1 protein was increased in goblet cells in SN-Asthmatics and increased in SN-Asthmatic BAL fluid. | 28775743 |
| 233 | Asthma | Human | Serum, Broncho Alveolar Lavage Fluid (BALF) | FSTL1 | ELISA | Others | Low Throughput | Plasma FSTL1 levels were higher in asthmatics than in controls. FSTL1 levels in asthmatics were linked with increased smooth muscle mass and thickened Reticular Basement Membrane. FSTL1 may contribute to airway remodeling in asthmatics. | 28845090 |
| 234 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL1 | Meso Scale Discovery System | Others | Low Throughput | The median concentrations of IL1 were significantly elevated in BALF from subjects with asthma compared with controls. The concentrations of IL1 were significantly higher in mild and moderate/severe asthma than those of controls. | 28836545 |
| 235 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | TNFalpha | Meso Scale Discovery System | Others | Low Throughput | The median concentrations of TNFalpha was significantly increased in the BALF of mild and moderate/severe asthmatics compared with those of controls. The median concentrations of TNFalpha were significantly greater in BALF from moderate/severe asthma than those of mild asthma. TNFalpha concentration was negatively associated with the severity of the disease (lung function forced expiratory volume in 1 s). | 28836545 |
| 236 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL6 | Meso Scale Discovery System | Others | Low Throughput | The median concentrations of IL6 were significantly elevated in BALF of mild and moderate/severe asthma compared with those in controls. The median concentrations of IL6 were also greater in BALF of moderate/severe asthma than those in mild asthma. | 28836545 |
| 237 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CXCL8 | Meso Scale Discovery System | Others | Low Throughput | The median concentrations of CXCL8 (IL-8) were significantly higher in BALF of mild and moderate/severe asthma compared with those of controls. The median concentrations of CXCL8 were significantly greater in BALF of moderate/severe asthma than those of mild asthma. CXCL8 concentration was negatively associated with the severity of the disease (lung function forced expiratory volume in 1 s). | 28836545 |
| 238 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CXCL10 | Meso Scale Discovery System | Others | Low Throughput | The median concentrations of CXCL10 (IP-10) were significantly elevated in BALF of moderate/severe asthma compared with those of controls and with mild asthmatics. | 28836545 |
| 239 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CCL4 | Meso Scale Discovery System | Others | Low Throughput | Concentrations CCL4 was significantly greater in BALF from total asthmatics as compared with controls. CCL4 level was significantly elevated in the BALF of mild asthma compared with those of controls. | 28836545 |
| 240 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CCL11 | Meso Scale Discovery System | Others | Low Throughput | Concentrations CCL11 was significantly greater in BALF from total asthmatics as compared with controls. CCL11 level was significantly elevated in the BALF of mild asthma compared with those of controls. Concentrations of CCL11 were significantly higher in BALF of moderate/severe asthma than those of mild asthma. | 28836545 |
| 241 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CCL17 | Meso Scale Discovery System | Others | Low Throughput | Concentrations CCL17 was significantly greater in BALF from total asthmatics as compared with controls. CCL17 level was significantly elevated in the BALF of mild asthma compared with those of controls. | 28836545 |
| 242 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CCL22 | Meso Scale Discovery System | Others | Low Throughput | CCL22 level was significantly elevated in the BALF of mild asthma compared with those of controls. | 28836545 |
| 243 | Asthma and Viral Airway Pathology | Human, Mouse (Male C57BL/6J mice) | Bronchial Brushings, Nasal Washes, Lungs, Broncho Alveolar Lavage Fluid (BALF) | BMAL1 | qRT-PCR, Luminex Multiplex Assay | Others | Low Throughput, High Throughput | BMAL1 is found to link the circadian clock to viral airway pathology and asthma phenotypes. | 28401936 |
| 244 | Asthma (OVA Induced Asthma) | Human, Mouse (Female BALB/c mice) | Lung Tissues, Broncho Alveolar Lavage Fluid (BALF) | IL37 | qRT-PCR, Western Blotting, ELISA | Genomics, Proteomics, Others | Low Throughput | Human Interleukin-37 alleviates airway inflammation and remodeling in asthmatic mice via inhibiting the cctivation of Nfkb and Stat3 Signalings. | 29268192 |
| 245 | Allergic Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | DEL-1 | ELISA | Others | Low Throughput | Del-1 was markedly lower in BALF of asthmatic patients compared with healthy controls. | 29437247 |
| 246 | Allergic Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL17 | ELISA | Others | Low Throughput | IL17 expression was greater in BALF from allergic asthma compared with control subjects. | 29437247 |
| 247 | Asthma | Human | Bronchial Biopsy, Broncho Alveolar Lavage Fluid (BALF) | MUC5AC | qRT-PCR, ELISA | Genomics, Others | Low Throughput | Hypersecretion and overexpression of MUC5AC were detected in all patients with asthma compared with control group. | 29031476 |
| 248 | Asthma | Human | Serum, Broncho Alveolar Lavage Fluid (BALF) | CC16 | ELISA | Others | Low Throughput | CC16 level was reduced in serum and BALF of asthmatics as compared to healthy subjects. | 27315766 |
| 249 | Atopic Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | GCSF | Bioplex Cytokine Assay | Others | Low Throughput | Asthma patients with mild or moderate obstruction (AP1) had significantly decreased concentrations of GCSF compared to asthma patients with significantly more obstruction and lower FEV1 (AP2) and controls. | 29053714 |
| 250 | Atopic Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IFNG | Bioplex Cytokine Assay | Others | Low Throughput | Asthma patients with mild or moderate obstruction (AP1) had significantly decreased concentrations of IFNG compared to asthma patients with significantly more obstruction and lower FEV1 (AP2) and controls. | 29053714 |
| 251 | Atopic Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL17F | Bioplex Cytokine Assay | Others | Low Throughput | Asthma patients with mild or moderate obstruction (AP1) had significantly decreased concentrations of IL17F compared to asthma patients with significantly more obstruction and lower FEV1 (AP2) and controls. | 29053714 |
| 252 | Atopic Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL2 | Bioplex Cytokine Assay | Others | Low Throughput | Asthma patients with significantly more obstruction and lower FEV1 (AP2) had significantly decreased concentrations of IL2 compared to asthma patients with mild or moderate obstruction (AP1) and controls. IL2 was associated significantly with obstructive airway status. | 29053714 |
| 253 | Atopic Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL10 | Bioplex Cytokine Assay | Others | Low Throughput | Asthma patients with significantly more obstruction and lower FEV1 (AP2) had significantly decreased concentrations of IL10 compared to asthma patients with mild or moderate obstruction (AP1) and controls. | 29053714 |
| 254 | Atopic Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | CCL4 | Bioplex Cytokine Assay | Others | Low Throughput | Asthma patients with significantly more obstruction and lower FEV1 (AP2) had significantly increased concentrations of CCL4 compared to with mild or moderate obstruction (AP1) and controls. CCL4 was associated significantly with obstructive airway status. | 29053714 |
| 255 | Atopic Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | TNFalpha | Bioplex Cytokine Assay | Others | Low Throughput | Asthma patients with significantly more obstruction and lower FEV1 (AP2) had significantly increased concentrations of TNFalpha compared to with mild or moderate obstruction (AP1) and controls. | 29053714 |
| 256 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | α-MSH | ELISA | Others | Low Throughput | α-MSH levels in BALF of asthmatic individuals were significantly higher compared to healthy controls. | 30980429 |
| 257 | Asthma (In Infants) | Human | Broncho Alveolar Lavage Fluid (BALF) | Let-7a | qRT-PCR | Genomics | Low Throughput | The increased expression of miRNA-let 7a was associated with the asthma of infants. | 30789054 |
| 258 | Asthma (In Infants) | Human | Broncho Alveolar Lavage Fluid (BALF) | Let-7b | qRT-PCR | Genomics | Low Throughput | The increased expression of miRNA-let 7b was associated with the asthma of infants. | 30789054 |
| 259 | Asthma (In Infants) | Human | Broncho Alveolar Lavage Fluid (BALF) | Let-7c | qRT-PCR | Genomics | Low Throughput | The increased expression of miRNA-let 7c was associated with the asthma of infants. | 30789054 |
| 260 | Asthma | Human | Macrophages from Broncho Alveolar Lavage Fluid (BALF) (Stimulated by HDM) | APOE | ELISA | Others | Low Throughput | HDM induces APOE secretion from BALF macrophages from asthmatic subjects. HDM derived cysteine and serine proteases induce secretion of APOE from BALF macrophages from asthmatic subjects through PAR-2. APOE at concentrations that exceed those normally found in lung epithelial lining fluid (ELF) from healthy subjects both primes and activates the NLRP3 inflammasome in BALF macrophages from asthmatic subjects to induce IL1B secretion. Similar observations were made in HDM and APOE stimulated female BALB/c mice. | 30872118 |
| 261 | Asthma | Human | Macrophages from Broncho Alveolar Lavage Fluid (BALF) (Stimulated by HDM), Broncho Alveolar Lavage Fluid (BALF) Macrophage Cell Lysate | IL1B | ELISA, Western Blotting | Others, Proteomics | Low Throughput | HDM induces increased IL1B secretion from BALF macrophages from asthmatic subjects, compared with cells that were treated with media alone. HDM also induced increased pro IL1B expression in BALF macrophage cell lysate. | 30872118 |
| 262 | Asthma | Human | Macrophages from Broncho Alveolar Lavage Fluid (BALF) (Stimulated by HDM) | TNFalpha | ELISA | Others | Low Throughput | HDM induces increased TNFalpha secretion from BALF macrophages from asthmatic subjects. | 30872118 |
| 263 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) Macrophage Cell Lysate | NLRP3 | Western Blotting | Proteomics | Low Throughput | HDM induces increased NLRP3 expression in cell lysate of BALF macrophages from asthmatic subjects, compared with cells that were treated with media alone. | 30872118 |
| 264 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) Macrophage Cell Lysate | CASP1 | Western Blotting | Proteomics | Low Throughput | HDM induced processing of the full-length pro–caspase-1 to generate the active caspase-1 in BALF macrophage cell lysate from asthmatics. | 30872118 |
| 265 | Asthma | Human | Serum, Broncho Alveolar Lavage Fluid (BALF), Bronchial Tissue | IL31 | ELISA, Immunohistochemistry | Others | Low Throughput | Serum and BALF IL31 levels were significantly elevated in patients with asthma compared with controls. Expression of IL31 was more prominent in the bronchial tissue in severe compared to mild asthma and controls. | 26956917 |
| 266 | Obese Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | SP-A | Western Blotting, ELISA | Proteomics, Others | Low Throughput | Significantly less SP-A was detected in samples from Obese Asthmatics as compared with those from control subjects. | 28624607 |
| 267 | Severe Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | TSLP | ELISA | Others | Low Throughput | TSLP level in BALF of asthmatics was significantly elevated as compared to healthy controls. BAL fluid TSLP levels correlated with steroid resistance of ILC2s (Type 2 Innate Lymphoid Cells). | 28433687 |
| 268 | Severe Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | SAA | ELISA | Others | Low Throughput | Bronchoalveolar lavage fluid (BALF) SAA level was increased in severe asthmatics relative to non severe asthmatics. | 28724795 |
| 269 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL33 | Meso Scale Discovery System (ELISA) | Others | High Throughput | The median concentration of IL33 was significantly elevated in BALF from asthmatic patients compared with controls. It was significantly elevated in asthmatic patients treated with ICS, with or without additional oral corticosteroids, compared with those not so treated. | 29453280 |
| 270 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | TSLP | Meso Scale Discovery System (ELISA) | Others | High Throughput | The median concentration of TSLP was significantly elevated in BALF from asthmatic patients compared with controls. It was significantly elevated in asthmatic patients treated with ICS, with or without additional oral corticosteroids, compared with those not so treated. | 29453280 |
| 271 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL4 | Meso Scale Discovery System (ELISA) | Others | High Throughput | The median concentration of IL4 was significantly elevated in BALF from asthmatic patients compared with controls. The median concentration of IL4 was significantly elevated in BALF from asthmatic patients not treated with steroids as compared with controls. | 29453280 |
| 272 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL5 | Meso Scale Discovery System (ELISA) | Others | High Throughput | The median concentration of IL5 was significantly elevated in BALF from asthmatic patients compared with controls. | 29453280 |
| 273 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL13 | Meso Scale Discovery System (ELISA) | Others | High Throughput | The median concentration of IL13 was significantly elevated in BALF from asthmatic patients compared with controls. The median concentration of IL13 was significantly elevated in BALF from asthmatic patients not treated with steroids as compared with controls. | 29453280 |
| 274 | Asthma | Human | Broncho Alveolar Lavage Fluid (BALF) | IL12p70 | Meso Scale Discovery System (ELISA) | Others | High Throughput | The median concentration of IL12p70 was significantly elevated in BALF from asthmatic patients compared with controls. | 29453280 |
| 275 | Atopic Asthma (Following Allergen Challenge) | Human | Sputum, Broncho Alveolar Lavage Fluid (BALF) | IL5 | Meso Scale Discovery System (ELISA) | Others | High Throughput | IL5 level was increased post allergen challenge. | 29651336 |
| 276 | Atopic Asthma (Following Allergen Challenge) | Human | Sputum, Broncho Alveolar Lavage Fluid (BALF) | ECP | Meso Scale Discovery System (ELISA) | Others | High Throughput | ECP level was increased post allergen challenge. | 29651336 |
| 277 | Asthma | Human | Lung Lysate, Broncho Alveolar Lavage fluid (BALF), Serum | INPP4A | Western Blotting, ELISA | Proteomics, Others | Low Throughput | INPP4A expression was significantly reduced in lung lysate, BALF and serum of asthma patients as compared to that from healthy controls. | 30335467 |
| 278 | Asthma | Human | CD4 T cells from Broncho Alveolar Lavage Fluid (BALF) | BcL2L12 | qRT-PCR, Western Blotting | Genomics, Proteomics | Low Throughput | BcL2L12 expression was significantly increased in asthmatic patients as compared to healthy subjects. BcL2L12 was corelated with FEV1 and TH2 cytokines in BAL fluid CD4 T cells of asthmatic patients. | 30227178 |
| 279 | Asthma | Human | CD4 T cells from Broncho Alveolar Lavage Fluid (BALF) | IL4 | Flow Cytometry, ELISA, qRT-PCR | Others, Genomics | Low Throughput | IL4 expression was significantly increased in asthmatic patients as compared to healthy subjects. | 30227178 |
| 280 | Asthma | Human | CD4 T cells from Broncho Alveolar Lavage Fluid (BALF) | IL5 | Flow Cytometry, ELISA, qRT-PCR | Others, Genomics | Low Throughput | IL5 expression was significantly increased in asthmatic patients as compared to healthy subjects. | 30227178 |
| 281 | Asthma | Human | CD4 T cells from Broncho Alveolar Lavage Fluid (BALF) | IL13 | Flow Cytometry, ELISA, qRT-PCR | Others, Genomics | Low Throughput | IL13 expression was significantly increased in asthmatic patients as compared to healthy subjects. | 30227178 |
| 282 | Asthma | Human | CD4 T cells from Broncho Alveolar Lavage Fluid (BALF) | IFNG | Flow Cytometry, ELISA, qRT-PCR | Others, Genomics | Low Throughput | IFNG expression was significantly decreased in asthmatic patients as compared to healthy subjects. | 30227178 |
| 283 | Asthma | Human | CD4 T cells from Broncho Alveolar Lavage Fluid (BALF) | TNF | Flow Cytometry, ELISA, qRT-PCR | Others, Genomics | Low Throughput | TNF expression was significantly decreased in asthmatic patients as compared to healthy subjects. | 30227178 |
| 284 | Asthma | Human | CD4 T cells from Broncho Alveolar Lavage Fluid (BALF) | IL17 | Flow Cytometry, ELISA, qRT-PCR | Others, Genomics | Low Throughput | IL17 expression was significantly decreased in asthmatic patients as compared to healthy subjects. | 30227178 |
| 285 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL1B | ELISA | Others | Low Throughput | Th2/Th17-predominant asthma had elevated IL1B in BAL as compared to Th2 predominant asthma and Th2/Th17 low asthma. | 27702673 |
| 286 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL6 | ELISA | Others | Low Throughput | Th2/Th17-predominant asthma had elevated IL6 in BAL as compared to Th2 predominant asthma and Th2/Th17 low asthma. | 27702673 |
| 287 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL23 | ELISA | Others | Low Throughput | Th2/Th17-predominant asthma had elevated IL23 in BAL as compared to Th2 predominant asthma and Th2/Th17 low asthma. | 27702673 |
| 288 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | C3a | ELISA | Others | Low Throughput | Th2/Th17-predominant asthma had elevated C3a in BAL as compared to Th2 predominant asthma and Th2/Th17 low asthma. | 27702673 |
| 289 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | SAA | ELISA | Others | Low Throughput | Th2/Th17-predominant asthma had elevated SAA in BAL as compared to Th2 predominant asthma and Th2/Th17 low asthma. | 27702673 |
| 290 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL1A | ELISA | Others | Low Throughput | Th2/Th17 low asthma had elevated IL1A in BAL as compared to Th2 predominant asthma and Th2/Th17 predominant asthma. | 27702673 |
| 291 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | MPO | ELISA | Others | Low Throughput | Th2/Th17 low asthma had elevated MPO in BAL as compared to Th2 predominant asthma and Th2/Th17 predominant asthma. | 27702673 |
| 292 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL8 | ELISA | Others | Low Throughput | Th2/Th17 low asthma had elevated IL8 in BAL as compared to Th2 predominant asthma and Th2/Th17 predominant asthma. | 27702673 |
| 293 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | IL17A | ELISA | Others | Low Throughput | Th2/Th17-predominant asthma had elevated IL17A in BAL as compared to Th2 predominant asthma and Th2/Th17 low asthma. | 27702673 |
| 294 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | G-CSF | ELISA | Others | Low Throughput | Th2/Th17 low asthma had elevated G-CSF in BAL as compared to Th2 predominant asthma and Th2/Th17 predominant asthma. | 27702673 |
| 295 | Asthma (Th2 Predominant Asthma, Th2/Th17 Predominant Asthma, Th2/Th17 Low Asthma) | Human | Broncho Alveolar Lavage Fluid (BALF) | GM-CSF | ELISA | Others | Low Throughput | Th2/Th17 low asthma had elevated GM-CSF in BAL as compared to Th2 predominant asthma and Th2/Th17 predominant asthma. | 27702673 |